First Covid-19 Patient Treated With Hungarian-Made Remdesivir Leaves Hospital

  • 27 Oct 2020 8:10 AM
  • Hungary Matters
First Covid-19 Patient Treated With Hungarian-Made Remdesivir Leaves Hospital
A 75 year old woman, the first Covid-19 patient to be treated with Remdesivir produced in Hungary, has been released from hospital, the Budapest Semmelweis University said.

The diabetic patient admitted to hospital with serious pneumonia on October 14 immediately received a combined therapy that included doses of Remdesivir, the university said, adding that the therapy had significantly improved her condition.

The patient is now convalescing in her home, it added.

According to the university, 19 patients have so far received Remdesivir manufactured by Hungarian pharma company Richter Gedeon.

Remdesivir, a virus inhibitor, is given to Covid-19 patients hospitalised with a serious condition.

Clinical trials of Richter’s Remdesivir in Hungary started in mid-October, with all four medical universities of the country participating.

The drug was approved by the US Food and Drug Administration on October 22.


MTI Photo: Zsolt Czeglédi

  • How does this content make you feel?

XpatLoop Media Partner

Hungary Matters

Launched in January 2014, this twice-daily newsletter covers 'everything you need to know about what’s going on in Hungary and beyond', according to its publisher the state media agency MTI. Click the title above for more info, and to subscribe.

Explore More Reports

  • Egis Favipiravir Drug Licenced For Covid-19 Treatment

    Egis Favipiravir Drug Licenced For Covid-19 Treatment

    • 21 Dec 2020 10:01 AM

    A new drug with the active ingredient favipiravir manufactured by Hungarian pharmaceutical company Egis has been licenced for treatment of Covid-19 by the National Institute of Pharmacy and Nutrition (OGYÉI), the institute said on Saturday.

  • Manufacture Of Covid Drug Remdesivir Under Way In Hungary

    Manufacture Of Covid Drug Remdesivir Under Way In Hungary

    • 12 Oct 2020 7:54 AM

    Domestic manufacture of the Covid-19 drug Remdesivir is under way in Hungary, with pharmaceutical company Richter having manufactured enough clinical trial doses in the initial phase to treat some 250 patients, the innovation and technology ministry said.